Acute Myeloid Leukemia Clinical Trial
An Inpatient Advanced Care Practitioner-delivered Advance Care Planning Intervention for Older Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
Summary
This is a pilot study to assess the preliminary efficacy of an inpatient advanced care practitioner (APP)-delivered advance care planning intervention on outcomes in older patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
Full Description
Older adults with AML and MDS receive more aggressive inpatient care at the end of life compared to patients with solid tumors. Advance care planning may promote early serious illness conversations for patients with AML and MDS, leading to less aggressive healthcare utilization at the end of life. This pilot aims to assess the preliminary efficacy of an inpatient APP-delivered advance care planning intervention on outcomes in older patients with AML and MDS.
Eligibility Criteria
Inclusion Criteria:
Age ≥60 years
A diagnosis of AML or high or very high risk MDS defined by IPSS-R
Able to provide informed consent
Being managed in the inpatient setting
English-speaking
Exclusion Criteria:
None
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Rochester New York, 14642, United States More Info
Principal Investigator
Sub-Investigator
How clear is this clinincal trial information?